Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers Lindsey M. R. CassConstantin EfthymiopoulosAlan Bye Original Research Article 25 November 2012 Pages: 1 - 11
Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir Lindsey M. R. CassConstantin EfthymiopoulosAlan Bye Original Research Article 25 November 2012 Pages: 13 - 19
Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers Lindsey M. R. CassJoanne BrownAlan Bye Original Research Article 25 November 2012 Pages: 21 - 31
Deposition and Disposition of [11C]Zanamivir Following Administration as an Intranasal Spray Mats BergstromLindsey M. R. CassBengt Langstrom Original Research Article 25 November 2012 Pages: 33 - 39
The Low Potential for Drug Interactions with Zanamivir Mick J. DanielJacqueline M. BarnettBridget A. Pearson Original Research Article 25 November 2012 Pages: 41 - 50
Coadministration of Orally Inhaled Zanamivir with Inactivated Trivalent Influenza Vaccine Does Not Adversely Affect the Production of Antihaemagglutinin Antibodies in the Serum of Healthy Volunteers Alison WebsterMalcolm BoyceIrene Miller Original Research Article 25 November 2012 Pages: 51 - 58
